BioVaxys Technology Corp.
BioVaxys Technology Corp.
BioVaxys Technology Corp. est une société d'immunothérapie au stade clinique développant des plates-formes vaccinales contre le SRAS-CoV-2 et divers cancers.
BioVaxys Technology Corp. (BIOV)
BioVaxys Technology Corp. (BIOV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
BMO Nesbitt Burns Inc. | 36,000 | 0.05 | 0.05 | 14,000 | CIBC World Markets Inc. |
TD Securities Inc. | 23,000 | 0.045 | 0.05 | 5,000 | Anonymous |
W.D. Latimer Co. Limited | 5,000 | 0.045 | 0.05 | 33,000 | RBC Capital Markets |
BMO Nesbitt Burns Inc. | 8,000 | 0.04 | 0.05 | 14,000 | National Bank Financial Inc. |
BMO Nesbitt Burns Inc. | 8,000 | 0.04 | 0.055 | 62,000 | Anonymous |
BMO Nesbitt Burns Inc. | 8,000 | 0.04 | 0.055 | 40,000 | CIBC World Markets Inc. |
BMO Nesbitt Burns Inc. | 8,000 | 0.04 | 0.055 | 1,000 | TD Securities Inc. |
BMO Nesbitt Burns Inc. | 10,000 | 0.04 | 0.055 | 7,000 | TD Securities Inc. |
TD Securities Inc. | 5,000 | 0.04 | 0.055 | 1,000 | TD Securities Inc. |
Anonymous | 60,000 | 0.04 | 0.055 | 1,000 | National Bank Financial Inc. |
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
Anonymous | 20,000 | 0.045 | 0.00 | 0 | |
Anonymous | 65,000 | 0.04 | 0.00 | 0 | |
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
1 | 36,000 | 0.05 | 0.05 | 66,000 | 4 |
2 | 28,000 | 0.045 | 0.055 | 113,000 | 7 |
13 | 224,000 | 0.04 | 0.06 | 130,000 | 10 |
3 | 70,000 | 0.035 | 0.065 | 246,000 | 18 |
1 | 25,000 | 0.03 | 0.07 | 177,000 | 10 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
1 | 20,000 | 0.045 | 0.00 | 0 | 0 |
1 | 65,000 | 0.04 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
---|---|---|---|---|---|---|
Feb 14, 15:01 | 0.045 | 0.00 | 18,000 | BMO Nesbitt Burns Inc. | Anonymous | CSE |
Feb 14, 14:42 | 0.045 | 0.00 | 4,000 | Merrill Lynch Canada Inc. | Anonymous | CSE |
Feb 14, 14:42 | 0.045 | 0.00 | 2,000 | National Bank Financial Inc. | Anonymous | CSE |
Feb 14, 14:40 | 0.045 | 0.00 | 6,000 | Anonymous | Anonymous | CSE |
Feb 14, 14:40 | 0.045 | 0.00 | 6,000 | Anonymous | Anonymous | CSE |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Bulletins
2024-0715 - Réintégration - BioVaxys Technology Corp. (BIOV)
le 16 juillet/July 2024
Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.